US Stock MarketDetailed Quotes

VCEL Vericel

Watchlist
  • 51.870
  • -0.980-1.85%
Trading Feb 27 11:48 ET
2.56BMarket Cap648.38P/E (TTM)

Vericel Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vericel Q4 2024 Estimates Date

Currency：USDFeb 27, 2025

Estimate YoY
Revenue
76.47M
+17.66%
EPS
0.35
+33.65%
Analyst Rating
Strong Buy

Feb 27, 2025

Vericel Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 64.968M--
--2025/Q1-- / 60.225M--
Feb 27, 20252024/Q475.376M / 76.475M--
Nov 7, 20242024/Q357.905M / 55.202M--
Aug 1, 20242024/Q252.662M / 52.592M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 64.968M--
--2025/Q1-- / 60.225M--
Feb 27, 20252024/Q475.376M / 76.475M--
Nov 7, 20242024/Q357.905M / 55.202M--
Aug 1, 20242024/Q252.662M / 52.592M--

Unlock Free Earnings Estimates

Vericel Earnings Reports

  • Vericel | 10-K: Annual report

    Feb 27 08:58 ET

  • Vericel | 8-K: Press Release of Vericel Corporation, “Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results”

    Feb 27 08:02 ET

  • Vericel | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 08:53 ET

  • Vericel | 8-K: Press Release of Vericel Corporation, “Vericel Reports Third Quarter 2024 Financial Results”

    Nov 7, 2024 08:03 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Halozyme Therapeutics
    HALO
    +1.12%
    Collegium Pharmaceutical
    COLL
    +1.09%
    Precision Drilling
    PDS
    +0.74%
    Hutchmed (China)
    HCM
    +0.54%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 27, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday+0.06%